Utility of Albusure test in screening for early stage of diabetic nephropathy.

J. Zhang, K. Lnoue, N. Nakashima, S. Hiramatsu, M. Ohashi, F. Umeda, H. Nawata

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


All diabetic patients should be screened for the early stage of diabetic nephropathy, because microalbuminuria has a great prognostic significance. The albusure test (AT), alatex agglutination nephelometric immunoassay, is a rapid and low cost test for the detection of microalbuminuria of 30 mg/L or more. We compared the results of AT and of radioimmunoassay (RIA) for urinary albumin to evaluate the clinical utility of AT using fresh urine samples from 74 diabetic patients without persistent proteinuria and from 11 healthy subjects. Urinary albumin levels measured by RIA were 6.0 +/- 2.3 mg/L in the healthy subjects, 11.0 +/- 8.7 mg/L in the AT-negative group (n = 61), and 38.1 +/- 10.2 mg/L in the AT-positive group (n = 13). Using a cut-off value of 30 mg/L by RIA, the rate of coincidence between AT and RIA was 89.2%, although five subjects were false-positive by AT, and three were false-negative. These results show that AT may provide a useful monitor microalbuminuria, a reliable early mark of diabetic nephropathy.

Original languageEnglish
Pages (from-to)699-702
Number of pages4
JournalChinese medical journal
Issue number9
Publication statusPublished - 1994
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • General Medicine


Dive into the research topics of 'Utility of Albusure test in screening for early stage of diabetic nephropathy.'. Together they form a unique fingerprint.

Cite this